1. Home
  2. HOTH vs SNAL Comparison

HOTH vs SNAL Comparison

Compare HOTH & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

HOLD

Current Price

$0.56

Market Cap

17.7M

Sector

Health Care

ML Signal

HOLD

Logo Snail Inc.

SNAL

Snail Inc.

HOLD

Current Price

$0.51

Market Cap

19.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOTH
SNAL
Founded
2017
2000
Country
United States
United States
Employees
N/A
166
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
19.3M
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
HOTH
SNAL
Price
$0.56
$0.51
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
519.1K
22.0K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
29.69
120.00
EPS
N/A
N/A
Revenue
N/A
$81,225,622.00
Revenue This Year
N/A
$49.44
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.48
52 Week High
$2.12
$2.15

Technical Indicators

Market Signals
Indicator
HOTH
SNAL
Relative Strength Index (RSI) 27.59 31.97
Support Level N/A N/A
Resistance Level $1.12 $0.98
Average True Range (ATR) 0.08 0.05
MACD -0.04 -0.01
Stochastic Oscillator 10.86 17.31

Price Performance

Historical Comparison
HOTH
SNAL

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

About SNAL Snail Inc.

Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States. The Company has one operating and reportable segment. The company operates in the USA, the UK and Other Countries.

Share on Social Networks: